Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peoplePersonalized NK Cell Therapy in CBT
- Where
- Houston
- Age
- 15 years to 80 years
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT02727803 - Phase 2/3Taking peopleLong-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Where
- Albany, Ann Arbor, Atlanta, Aurora, Baltimore, Bethesda, Birmingham, Boston, Buffalo, Chapel Hill, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Denver, Detroit, Duarte, Durham, East Brunswick, Eugene, Gilbert, Greenville, Hackensack, Houston, Indianapolis, Jacksonville, La Jolla, Lexington, Los Angeles, Louisville, Madison, Maywood, Miami, Milwaukee, Minneapolis, Morristown, Nashville, New Brunswick, New Haven, New Orleans, New York, Niles, Norfolk, North Worcester, Oklahoma City, Omaha, Orlando, Philadelphia, Phoenix, Pittsburgh, Portland, Richmond, Rochester, Sacramento, Salisbury, Salt Lake City, San Antonio, San Francisco, Santa Monica, Scottsdale, Seattle, Sioux Falls, Southfield, Stanford, St Louis, Tacoma, Tampa, Temple, Tucson, Tyler, Washington D.C., Wauwatosa, Westwood, Wichita
- People
- 1,541 worldwide
- Run by
- Celgene
See details and how to joinNCT03435796 · EU 2023-504201-36-00 - Phase 1Taking peopleChemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
- Where
- Augusta
- Age
- 3 years to 25 years
- People
- 37
- Run by
- Theodore S. Johnson
See details and how to joinNCT05106296 - Phase 2Taking peopleA Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
- Where
- Basking Ridge, Bethesda, Commack, Harrison, Middletown, Montvale, New York, Pittsburgh, Uniondale
- Age
- 4 years and over
- People
- 44
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05675930 - Phase 2Taking peopleA Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
- Where
- Houston, New York
- Age
- 12 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06229912 - Phase 1Taking peopleAdoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma
- Where
- Gainesville, Washington D.C.
- Age
- 4 years to 30 years
- People
- 12
- Run by
- University of Florida
See details and how to joinNCT06514898 - Early phase 1Taking peoplePilot Study of TumorGlow for Intraoperative Molecular Imaging of Sarcoma Metastases to the Lungs in Pediatric Patients
- Where
- Phildelphia
- Age
- 12 years to 17 years
- People
- 20
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT07658768 - Phase 1Not yet taking people in United StatesA Study of CLEC2A CAR T for Pediatric and Adult Patients With Relapsed or Refractory AML
- Where
- Seattle
- Age
- Up to 70 years
- People
- 20
- Run by
- Seattle Children's Hospital
See details and how to joinNCT07905027 - Phase 1Taking peopleA Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
- Where
- Gainesville, Washington D.C.
- Age
- 4 years and over
- People
- 28
- Run by
- University of Florida
See details and how to joinNCT04573140 - Phase 1/2Taking peoplePhase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
- Where
- Gainesville, Miami, St. Petersburg
- Age
- Up to 50 years
- People
- 40
- Run by
- University of Florida
See details and how to joinNCT05322850 - Early phase 1Taking peopleIndocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors
- Where
- Chicago, Memphis, Pittsburgh
- Age
- Up to 20 years
- People
- 35
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT05645523 - Phase 3Taking peopleDinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Where
- Akron, Albany, Albuquerque, Allentown, Ann Arbor, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Bethesda, Birmingham, Boston, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Des Moines, Detroit, Downey, Duarte, Durham, El Paso, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Hollywood, Honolulu, Houston, Huntington, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madera, Madison, Marshfield, Memphis, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Nashville, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Portsmouth, Providence, Rochester, Royal Oak, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, St. Petersburg, Syracuse, Tacoma, The Bronx, Toledo, Tucson, Tulsa, Valhalla, Washington D.C., West Palm Beach, Wichita, Wilmington, Winston-Salem
- Age
- Up to 30 years
- People
- 478 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06172296 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Aurora, Boston, Fargo, Grand Rapids, Houston, Iowa City, Kansas City, Los Angeles, New Brunswick, New Haven, New York, Philadelphia, Portland, Salt Lake City, Sioux Falls, St. Petersburg, Valhalla
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - No phaseTaking peopleA Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
- Where
- Charlotte, Houston, Winston-Salem
- People
- 49
- Run by
- ARCE Therapeutics, Inc.
See details and how to joinNCT06906380 - Phase 3Taking peopleAn Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
- Where
- Rochester
- Age
- 6 months to 17 years
- People
- 20
- Run by
- Mayo Clinic
See details and how to joinNCT06915727 - Phase 1Not yet taking people in United StatesIL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)
- Where
- Gainesville
- Age
- 4 years to 30 years
- People
- 24
- Run by
- University of Florida
See details and how to joinNCT06946680 - No phaseNot yet taking people in United StatesPediatric Electrocutaneous Analgesia for Children Experiencing Neuropathic Pain
- Where
- Baltimore
- Age
- 5 years to 26 years
- People
- 70
- Run by
- Johns Hopkins University
See details and how to joinNCT07264920 - Phase 1Taking peopleA DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)
- Where
- Baltimore
- Age
- 12 years and over
- People
- 27
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT07430202 - Phase 1/2Taking peopleA Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- Where
- Aurora, Boston, Fargo, Grand Rapids, Houston, Iowa City, Kansas City, Los Angeles, New Brunswick, New York, Philadelphia, Salt Lake City, Sioux Falls, St. Petersburg, Valhalla
- Age
- 1 month to 17 years
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07630974 · EU 2025-522339-32-00 - No phaseNot yet taking people in United StatesThe AYA Oncology Self-care Movement
- Where
- Chicago, Houston, Philadelphia
- Age
- 15 years to 25 years
- People
- 200
- Run by
- Northwestern University
See details and how to joinNCT07724652 - No phaseTaking peopleClinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
- Where
- Bethesda
- Age
- 4 weeks to 99 years
- People
- 3,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00040352 - No phaseTaking peopleNatural History Study of GATA2 Deficiency and Related Disorders
- Where
- Bethesda
- Age
- 2 years to 100 years
- People
- 600
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT01905826 - No phaseTaking peopleObtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
- Where
- Bethesda
- Age
- 2 years and over
- People
- 1,800
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01915225 - No phaseTaking peopleDevelopment and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
- Where
- Baltimore, Bethesda, Chicago, Cincinnati, Philadelphia, Washington D.C.
- Age
- 5 years and over
- People
- 476
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02544022 - Phase 1Taking peopleMulti Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid Tumors
- Where
- Washington D.C.
- Age
- 1 year to 70 years
- People
- 14
- Run by
- Children's National Research Institute
See details and how to joinNCT05238792